Biotech · Private company
Areteia Therapeutics
Track this companyFree. Adds Areteia Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Dexpramipexole DihydrochloridePhase 3 · Eosinophilic AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Dexpramipexole DihydrochloridePhase 2 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPDPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 9, 2024ClinicalTrials.gov NCT06533553 · fetched Nov 12, 2026
- Phase III Long-Term Extension Study With DexpramipexolePHASE3 · TERMINATED · started Jun 12, 2024ClinicalTrials.gov NCT06388889 · fetched Nov 12, 2026
- A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)PHASE3 · TERMINATED · started Mar 27, 2023ClinicalTrials.gov NCT05813288 · fetched Nov 12, 2026
- A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic AsthmaPHASE3 · ACTIVE_NOT_RECRUITING · started Jan 30, 2023ClinicalTrials.gov NCT05748600 · fetched Nov 12, 2026
- A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.PHASE3 · TERMINATED · started Jan 30, 2023ClinicalTrials.gov NCT05763121 · fetched Nov 12, 2026